Business Insight Department
Mexico City, Mexico
Turn data into decisions that shape how millions of people access cardiometabolic care. In this role, you won't just crunch numbers – you'll listen, connect, and translate market intelligence into actionable recommendations that drive our commercial strategy forward.
Your new role
As a Consumer BI Coordinator within our Cardiometabolism Business Unit in Mexico, you will operate as an internal consultant – bridging the gap between data and decision-making. Your approach is built on a two-way dialogue: listening to your internal clients, sourcing insights from the market environment, and delivering recommendations grounded in evidence rather than assumptions.
Your key responsibilities will include:
Your new department
Within the Mexico Affiliate, the Business Insight team operates as an internal consultancy for the Cardiometabolism Business Unit. We combine market intelligence, consumer understanding, and analytical rigour to provide the recommendations that shape our commercial direction. Our team thrives on collaboration – listening first, then delivering insights that empower our stakeholders to make smarter, faster decisions.
Your skills & qualifications
To succeed in this role, you will bring:
Working at Novo Nordisk
Every day we seek the solutions that defeat serious chronic diseases. To do this, we approach our work with determination, constant curiosity and a commitment to finding better ways forward. For over 100 years, this dedication has driven us to build a company focused on lasting change for long-term health. One where diverse thinking, shared purpose and mutual respect come together to create extraordinary results. When you join us, you're not just starting a job – you're becoming part of a story that spans generations.
Deadline
31 July 2025. Applications are reviewed on an ongoing basis.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.
We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic diseases and promote long-term health. Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and treat, prevent, and even cure diseases that affect millions of lives. Because it takes an unordinary approach to drive real, lasting change in health.

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.
Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html